Abstract
BackgroundDrug costs constitute a major part of health expenditure in Turkey. Among drug classes, antineoplastics are the most expensive. Another attempt at cost savings in antineoplastic drugs could be achieved...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have